| The
value of our program is grounded
in the development and continuous refinement
of treatment protocols by the Scientific
Advisory Board (SAB). The SAB
was created in response to two major
events in the development of cancer
treatments and research.
|
|
| Scientific
Advisory Board...
The
SAB initially consisted of 18 world
renowned Radiation Oncologists who first
met in Detroit in February 1994. At that
time a consensus was reached on how the
guidelines for evidence-based recommendations
would be developed. Each SAB member
volunteered to help in the development in
areas of his/her expertise. With help from
ISH clinical staff initial guidelines
were produced for the top 20 diagnosed male
and female cancers by July 1994. These guidelines
were then distributed to the entire SAB
for review and comment.
A
second Detroit meeting was held in February
1995 at which time final agreement and consensus
was completed. Since that time the SAB
has expanded and a review of guidelines
is done on a continuous timeline.
Today,
ISH has consensus guidelines for
over 96% of all diagnosed male and female
adult cancers. The SAB has also been
expanded to include a world-renowned panel
of Medical Oncologists (chemotherapists),
Surgical Oncologists, Radiologists and support
personnel such as radiation oncology therapists
and nurses.
The
ongoing mission of the SAB
is not only to keep the guidelines
up to date, including any new information
on cancer treatment improvements,
but also to help analyze data already
collected by the system. In this way they
can validate the guideline recommendations.
|
|
|
The
SAB is comprised of individuals
with both national & international
reputations, who bring to the effort
respectability, credibility and a broad
based scientific background to develop
the criteria for quality care.
As part of the SAB's historical
mission, the SAB is currently
working to bring medical oncology
and surgical oncology into the
ISH Program and to develop programs,
which will be more properly, and effectively,
centered on integrated and multi-modal
management for cancer. |
|
| Today,
the Scientific Advisory Board
has been expanded to over 50 world-renowned
radiation, medical and surgical
oncologists from leading institutions,
including MD Anderson, Sloan
Kettering, UCLA, Beth
Israel, Hahnemann, Medical
College of Virginia, and Mallinckrodt
Institute. The board members meet
to provide unbiased peer support and
consultation on certain non-standard
cases and to update the treatment protocols
based on current literature, clinical
experience and outcomes review. Each
member of the SAB has signed
a three year agreement with us
that identifies their responsibilities
as a member of the SAB, attendance
at meetings, participation in similar
companies and reimbursement of expenses.
|
|
|
|
|
 |
|
